Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Basun

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Age and Ageing|January 13, 2005
Nutritional and cognitive relationships and long-term mortality in patients with various dementia disordersGerd Faxén-Irving, Hans Basun, Tommy Cederholm
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 6, 2002
Relationship between mercury concentration in blood, cognitive performance, and blood pressure, in an elderly urban populationNina Johansson, Hans Basun, Bengt Winblad, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 2, 2005
Porous graphitic carbon chromatography-tandem mass spectrometry for the study of isoprostanes in human cerebrospinal fluidKristina Claeson Bohnstedt, Bo Karlberg, Hans Basun, et al.
Journal of Sleep Research|May 25, 2005
A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathingStefan Torvaldsson, Ludger Grote, Yüksel Peker, et al.
Dementia and Geriatric Cognitive Disorders|September 10, 2002
Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrineHans Basun, Camilla Nilsberth, Christopher Eckman, et al.
Lakartidningen|January 18, 2006
[Conformationally altered proteins cause neurodegenerative diseases]Martin Ingelsson, Lars Nilsson, Hans Basun, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 5, 2003
Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 familySusanne Froelich Fabre, Pia Axelman, Asa Almkvist, et al.
Neurochemistry International|July 11, 2002
White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjectsLena Bronge, Lars-Olof Wahlund, Annelie Brauner, et al.
Alzheimer'S Research & Therapy|April 17, 2014
Performance on a pattern separation task by Alzheimer's patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levelsKeith A Wesnes, Peter Annas, Hans Basun, et al.
Lakartidningen|November 27, 2024
[New Alzheimer's treatments - a need for national preparations and coordination]Tobias Granberg, Anne Börjesson Hanson, David Fällmar, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Age and Ageing|January 13, 2005
Nutritional and cognitive relationships and long-term mortality in patients with various dementia disordersGerd Faxén-Irving, Hans Basun, Tommy Cederholm
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 6, 2002
Relationship between mercury concentration in blood, cognitive performance, and blood pressure, in an elderly urban populationNina Johansson, Hans Basun, Bengt Winblad, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 2, 2005
Porous graphitic carbon chromatography-tandem mass spectrometry for the study of isoprostanes in human cerebrospinal fluidKristina Claeson Bohnstedt, Bo Karlberg, Hans Basun, et al.
Journal of Sleep Research|May 25, 2005
A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathingStefan Torvaldsson, Ludger Grote, Yüksel Peker, et al.
Dementia and Geriatric Cognitive Disorders|September 10, 2002
Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrineHans Basun, Camilla Nilsberth, Christopher Eckman, et al.
Lakartidningen|January 18, 2006
[Conformationally altered proteins cause neurodegenerative diseases]Martin Ingelsson, Lars Nilsson, Hans Basun, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 5, 2003
Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 familySusanne Froelich Fabre, Pia Axelman, Asa Almkvist, et al.
Neurochemistry International|July 11, 2002
White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjectsLena Bronge, Lars-Olof Wahlund, Annelie Brauner, et al.
Alzheimer'S Research & Therapy|April 17, 2014
Performance on a pattern separation task by Alzheimer's patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levelsKeith A Wesnes, Peter Annas, Hans Basun, et al.
Lakartidningen|November 27, 2024
[New Alzheimer's treatments - a need for national preparations and coordination]Tobias Granberg, Anne Börjesson Hanson, David Fällmar, et al.
Pageof 6